Regen Biopharma issues 10M shares to CEO in settlement of $50K accrued salary

Regen BioPharma Inc

Issued 10,000,000 common shares to CEO David R. Koos as settlement for $50,000 of accrued unpaid salary.
Shares issued under Section 4(a)(2) exempt offering; no underwriters or commissions paid.
Settlement agreement (Ex-10.1) reveals total unpaid salary of $457,113.19; only $50K settled with shares.
Post-issuance, shares outstanding increased to 31,554,704 from ~21.6M, a ~46% dilution.

item 3.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.